People who took the daily pill orforglipron lost 12 percent of body weight on average after 72 weeks, according to clinical trial results from Lilly.

The new targeted pipeline will advance Nxera’s oral GLP-1 agonists, novel GPCR targets, and structure-based drug design to ...

The risk of new-onset diabetic retinopathy (DR) increased slightly, but significantly, in patients taking GLP-1 receptor ...

Accusing doctors of “dishing out” medications for weight loss and then labelling people “cheats” for using them is a ...

A review study published in the Annals of Internal Medicine looks at the effect of weight loss before IVF on reproductive outcomes. Prof Ying Cheong, Professor of Reproductive Medicine and Honorary ...